Back to search

Finland· FI-REL-REL59636

CZV Bovine Tuberculin PPD

A bovine tuberculin ppd product containing mycobacterium bovis, strain an-5 (purified protein derivative), registered in Finland.

ATC QI02AR01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedCZV Bovine Tuberculin PPDATCQI02AR01REGISTER NO.FI-REL-REL59636PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Mycobacterium bovis, strain AN-5 (purified protein derivative)
Manufacturer
—
Country
Finland (FI)
ATC code
QI02AR01
ATC class
Bovine tuberculin PPD
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2d3eceac-4097-45e6-91d9-44b441052ee8
GET /v1/drugs/2d3eceac-4097-45e6-91d9-44b441052ee8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste, liuos",
  "route": null,
  "ddd_unit": null,
  "strength": "2500 IU/0.1 ml",
  "atc_label": "Bovine tuberculin PPD",
  "ma_number": null,
  "auth_status": null,
  "eu_ma_number": null,
  "fimea_rel_id": "REL59636",
  "authorised_at": null
}

See everything about mycobacterium bovis, strain an-5 (purified protein derivative).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.